Has James Tober, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,170 in general payments to James Tober, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Tober, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Tober, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Tober, MD

Vascular Surgery · Beaufort, SCNPI 1538132931

Payments from drug & device makers

$1,170in general payments, 2019–2025

Across 11 payments — averaging $106.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Silk Road Medical, Inc.$1K
Abbott$28
Philips North America LLC$26
Boston Scientific$18
Lemaitre Vascular, Inc.$10

What the payments were for

Travel & lodging$90477%
Food & beverage$26623%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Silk Road Medical, Inc.	6	$1,088
Abbott	1	$28
Philips North America LLC	1	$26
Boston Scientific	1	$18
Lemaitre Vascular, Inc.	2	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENROUTE Transcarotid Neuroprotection System$1,004
ENROUTE Transcarotid Stent System$1,004
ENHANCE Transcarotid Peripheral Access Kit$1,004
ENROUTE 0.014 Guidewire$1,004

How this compares

$1,170 in reported general payments places this provider in the 5th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$207,914

Medicare patients

879

Services billed

1,960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	34	$27,941
Cilostazol	215	$4,812
Varenicline Tartrate	26	$4,316
Pentoxifylline	33	$1,372
ClopidogrelClopidogrel Bisulfate	112	$874
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$58
Tramadol Hcl	22	$39

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Beaufort

John RossOrangeburg$1M
Mathew WoosterWest Columbia$642K
David DeatonColumbia$609K
Sagar GandhiGreenville$443K
Joseph BlasGreenville$335K
Ravi VeeraswamyCharleston$273K
Jean Marie RuddyCharleston$210K
Gerald FortunaWest Columbia$178K
Kristian HochbergCharleston$106K
Thomas ApplebyNorth Charleston$89K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →